Report Shows DEA Deliberately Blocked Beneficial Science to Perpetuate War on Cannabis

By Claire Bernish

26th June 2016

Though it probably comes as no surprise, a new report confirms the U.S. Drug Enforcement Agency (DEA) systematically thwarted research into both cannabis and MDMA for medicinal use and potential rescheduling. Additionally, the Drug Policy Alliance and Multidisciplinary Association for Psychedelic Studies (MAPS) found in their report, the federal government maintains an “unjustifiable monopoly” on research-grade cannabis — preventing independent producers from contributing to any scientific studies.

According to the report, bluntly titled “The DEA: Four Decades of Impeding and Rejecting Science,” a compilation of case studies “illustrate a decades-long pattern of behavior that demonstrates the agency’s inability to exercise its responsibilities in a fair and impartial manner or to act in accord with the scientific evidence — often as determined by its Administrative Law Judges.”

In effecting inexcusably lengthy delays for cannabis research approval and refusing to reschedule the plant, the Drug Enforcement Agency has and continues to prevent countless people from obtaining crucial — in some cases, lifesaving — medicine they need.

CONTINUE READING:

FACEBOOK]: http://www.facebook.com/joinwakeupworld (An interactive community of over 3,000,000)

[PINTEREST]: http://pinterest.com/wakeupword/

[TWITTER]:  http://twitter.com/joinwakeupworld

[YOUTUBE]: http://www.youtube.com/joinwakeupworld          

[GOOGLE PLUS]: https://plus.google.com/112452105795129310867/posts

[WEBSITE]: http://wakeup-world.com